DePuy Orthopaedics, Inc., a Johnson & Johnson subsidiary, faces a recent DePuy ASR hip replacement symptoms lawsuit filed by a man alleging serious injuries and complications after the implantation of the hip replacement device.

Plaintiff Robert C. has filed a DePuy ASR hip replacement symptoms lawsuit which has joined a growing multidistrict litigation (MDL) against the company in Ohio federal court.

According to the DePuy ASR hip replacement systems lawsuit, Robert is a resident and citizen of the State of California. He says that he was implanted with the DePuy ASR hip implant on his right hip on Aug. 27, 2007 at Kaiser Permanente South Sacramento Medical Center, in Sacramento, California.

However, on or about July 5, 2017, he says that following the ASR hip device implantation, he suffered from “the occurrence of metallosis and the need for surgery to revise his right hip which has led to extreme physical pain and suffering.”

He also has experienced “the need for additional surgery, medical care and medical expenses in the past and the need for future medical care and expenses, lost past and future earnings and earning potential, and mental pain, suffering, distress, and anguish in the past and in to the future,” the DePuy ASR hip replacement symptoms lawsuit states.

The Depuy ASR hip replacement symptoms lawsuit was filed on multiple counts including negligence, negligence per se, defective design, manufacturing defect, failure to warn, breach of express warranty, breach of implied warranty, fraudulent misrepresentation, fraudulent concealment, fraud and deceit, among others.

Robert demands a trial by jury.

Overview: DePuy ASR Hip Replacement Symptoms Lawsuit

Serious side effects and complications have been linked to the DePuy ASR hip replacement device. It’s been the subject of a massive hip replacement device settlement because of these complications and injuries. Adverse side effects linked to the device includes:

• Cobalt poisoning
• Pseudotumors or non-cancerous tumors surrounding the hip implant
• Metal poisoning or metallosis that includes the presence of chromium or cobalt particles in the bloodstream or surrounding tissue
• Death of tissue
• The result of bone fractures from bone strength loss or structure
• Cancer
• Cardiomyopathy or Degenerative Heart Disease
• Hip Dislocation
• Metal hip implant failure resulting in early hip replacement surgery

DePuy is being accused of having known about these adverse effects complications. However, they allegedly failed to warn the medical community, patients and public of these complication leaving many patients to suffer extensive injuries as a result.

In fact, the first DePuy ASR trial revealed that DePuy knew that 2 out of 5 patients implanted with a DePuy replacement device would require a revision surgery in five years.

Additionally, DePuy issued a voluntary recall of its DePuy ASR hip replacement device on Aug. 24, 2010. The voluntary recall was later announced by the U.S. Food and Drug Administration (FDA). During the recall, nearly 93,000 replacement devices were effects worldwide, including almost 37,000 ASR hip replacement devices in the United States.

The DePuy ASR Hip Replacement Symptoms Lawsuit is Case No. 1:18-dp-20047-JJH, in the U.S. District Court for the Northern District of Ohio, Western Division. The DePuy MDL is in re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation, MDL No. 1:10-md-2197, in the U.S. District Court for the Northern District of Ohio, Western Division.